Overview

Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers

Status:
Completed
Trial end date:
2018-02-22
Target enrollment:
Participant gender:
Summary
This randomized phase I trial studies the side effects and best dose of linaclotide acetate in preventing colorectal cancer in healthy volunteers. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of linaclotide acetate may prevent colorectal cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Cancer Institute (NCI)
Treatments:
Linaclotide